Showing results (11-20 of 15) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Therapeutic Advances in Medical Oncology|June 11, 2020
Steroidal aromatase inhibitors have a more favorable effect on lipid profiles than nonsteroidal aromatase inhibitors in postmenopausal women with early breast cancer: a prospective cohort studyXue Wang, Anjie Zhu, Jiayu Wang, et al.Frontiers in Oncology|July 3, 2023
Efficacy of apatinib 250 mg combined with chemotherapy in patients with pretreated advanced breast cancer in a real-world settingRuyan Zhang, Yifei Chen, Xiaoran Liu, et al.Oncotarget|July 16, 2016
SPARC overexpression in primary tumors correlates with disease recurrence and overall survival in patients with triple negative breast cancerAnjie Zhu, Peng Yuan, Feng Du, et al.Breast Cancer Research and Treatment|May 13, 2020
Carboplatin plus taxanes are non-inferior to epirubicin plus cyclophosphamide followed by taxanes as adjuvant chemotherapy for early triple-negative breast cancerFeng Du, Wenmiao Wang, Yongsheng Wang, et al.Cancer Biology & Medicine|May 26, 2021
Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNAAnjie Zhu, Peng Yuan, Nanlin Hu, et al.Pageof 2